1 Min Read
Oct 4 (Reuters) - Summit Therapeutics :
* As per deal with Summit Therapeutics, Summit may get up to $330 million from Co in specified sales milestones on product-by-product basis Source text for Eikon: Further company coverage: ;))
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.